Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Enabling Genomic Technologies and Screening Asia 2014

Ramanuj Gupta's Biography



Ramanuj Gupta, Senior Investigator, Genome Institute of Singapore, A*STAR, NYU Cancer Institute

Dr. DasGupta is a Senior Investigator at the Genome Institute of Singapore (Cancer Therapeutics and Stratified Oncology). He also holds an adjunct Associate Professor position in the Department of Biochemistry and Molecular Pharmacology at the New York University Cancer Institute/Medical School, New York.

Dr. DasGupta received his Bachelor’s degree in Chemistry from St. Stephen’s College, Delhi, and a affiliated Master’s degree in Genetics from Cambridge University, UK. He then went on to do a Ph.D. in Developmental Biology at the University of Chicago.
Dr. DasGupta conducted his postdoctoral studies at the Harvard Medical School, Boston. He started his own laboratory at NYU School of Medicine/NYU Cancer Institute in 2005, and recently transitioned his research lab to the GIS, Singapore. Dr. DasGupta is the recipient of several national and international awards such as the Breast Cancer Research Foundation Concept Award (USA), Harold Weintraub Award (Fred Hutchinson Cancer Research Center), NYSTEM Idea Award (New York State), ACS Research Scholar Award (USA), March of Dimes Research Grant, the NYC BioAccelerate Prize, Wellcome Trust International Senior Research Fellowship, amongst others.

Ramanuj  Gupta Image

Novel and highly selective molecular tools to monitor and modulate activity of oncogenic b-catenin in Wnt-associated cancers

Thursday, 11 September 2014 at 09:00

Add to Calendar ▼SELECTBIOenquiries@selectbiosciences.com

The Wnt/b-catenin pathway is one of a core set of evolutionarily conserved signaling pathways that regulate many aspects of metazoan development. Inappropriate activation of the Wnt/b-catenin pathway has been associated with tumorigenesis of the liver, colon, breast and skin. Here we describe our recent effort at screening for novel and specific small molecule as well as peptido-mimetic inhibitors of oncogenic b-catenin that are being developed as novel therapeutic and molecular tools to study the function of this important pathway in the context of normal development, regeneration, and cancer.


Agenda is not currently available
Add to Calendar ▼2014-09-11 00:00:002014-09-12 00:00:00Europe/LondonEnabling Genomic Technologies and Screening Asia 2014Enabling Genomic Technologies and Screening Asia 2014 in SingaporeSingaporeSELECTBIOenquiries@selectbiosciences.com